Format

Send to

Choose Destination
Curr Opin Oncol. 1992 Dec;4(6):1073-9.

Cisplatin and platinum analogues: recent advances.

Author information

1
Department of Medicine, Brockton/W. Roxbury VAMC, MA 02401.

Abstract

Cisplatin is a critically important antineoplastic agent employed in treating patients who have a broad spectrum of neoplasms. Resistance to this agent poses a serious clinical dilemma. The objective of this review is to summarize the principal mechanisms that contribute to cytotoxicity by this agent and underlie resistance. Knowledge of these processes provides a rational basis for developing therapeutic strategies to circumvent resistance.

PMID:
1457521
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center